Combat Drugs (India) Financial Indicators Patterns

COMBDRG -- India Stock  

INR 28.35  0.90  3.28%

Use fundamental data analysis to double-check all available reported financial drivers of Combat Drugs Limited to find out if markets are presently mispricing the company. We found thirty available fundamental indicators for Combat Drugs Limited which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Combat Drugs Limited fundamentals including its Cash and Equivalents, Cash Flow from Operations and the relationship between Gross Profit and Debt to Equity . Use Combat Drugs to enhance returns of your portfolios. The stock experiences unexpected upward trend. Watch out for market signals. Check odds of Combat Drugs to be traded at 34.02 in 30 days

Combat Drugs Company Summary

Combat Drugs competes with Piramal Enterprises, Cipla, Torrent Pharmaceuticals, Abbott India, and Sanofi India. Combat Drugs Limited manufactures and markets pharmaceutical formulations in India. The company was founded in 1986 and is based in Hyderabad, India. Combat Drugs is traded on Bombay Stock Exchange in India.

Combat Drugs EBITDA vs Operating Margin

Combat Drugs Limited is rated below average in ebitda category among related companies. It is rated below average in operating margin category among related companies .

Combat Drugs Limited Systematic Risk

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Combat Drugs Limited correlated with the market. If Beta is less than 0 Combat Drugs generally moves in the opposite direction as compared to the market. If Combat Drugs Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Combat Drugs Limited is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Combat Drugs is generally in the same direction as the market. If Beta > 1 Combat Drugs moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

Distress Rating

Combat Drugs Financial Distress Probability

Chance of Financial Distress
Combat Drugs Limited has less than 22 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Combat Drugs Opportunity Range

September 25, 2018 Opportunity Range

Check also Trending Equities. Please also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.